P3: People Powering Protocols

The clinical trial industry has a problem--one that is exacerbated by flawed protocol designs, unrealistic inclusion/exclusion criteria, and other factors. Put simply, the industry must finally design trials around real-world patients and stop extrapolating narrow clinical trial data to wider patient populations.

Digital Biomarkers are Reshaping How Evidence is Generated in Clinical Research

As digital health technologies and the biomarkers they track become increasingly valuable tools for providing insights into patients' health in real-world settings, the authors of a forthcoming special feature for ACRP's Clinical Researcher journal say we are witnessing a reshaping of how evidence is generated in clinical research across multiple dimensions.

Still Timely After All These Years: How the Belmont Report Continues to Shape Research Ethics

In his August 20 ACRP Webinar on “Ethical Principles in Clinical Research,” presenter James Riddle, MSCE, CIP, CPIA, CRQM, Senior Vice President for Global Review Operations with Advarra, will explain how the Belmont Report has stood the test of time since its earliest days of formation to address ethical issues in human subject research in the 1970s, right up to the present.